Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of a New Innovative Method for the Easy Detection of a Disease Specific Marker to Make Prompt Diagnosis of Celiac Disease in All the Clinical Manifestations: a Paediatric Multicenter Study.

NCT06324539 is registered in ClinicalTrials.gov with IRCCS Burlo Garofolo as lead sponsor.

NCT NCT06324539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06324539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of a New Innovative Method for the Easy Detection of a Disease Specific Marker to Make Prompt Diagnosis of Celiac Disease in All the Clinical Manifestations: a Paediatric Multicenter Study.
Lead sponsor
IRCCS Burlo Garofolo
Phase
Observational
Overall status
Unknown status
Start date
October 4, 2023
Completion date
May 31, 2025
Enrollment
332 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

celiac disease in children